Why these ASX shares are in trading halts

Blue Sky Alternative Investments Ltd (ASX:BLA) shares are one of three in trading halts today. Here's why…

| More on:
a woman

You’re reading a free article with opinions that may differ from The Motley Fool’s Premium Investing Services. Become a Motley Fool member today to get instant access to our top analyst recommendations, in-depth research, investing resources, and more. Learn More

The market may be on course to have a strong finish to the week, but not all shares have been able to follow it higher today.

The three companies listed below have put their shares in trading halts this morning and are missing out on the positive investor sentiment. Here's why they are halted:

Animoca Brands Corporation Ltd (ASX: AB1) shares are in a trading halt whilst the mobile games company prepares an announcement relating to a proposed strategic investment. The company has requested that the trading halt remains in place until the earlier of commencement of normal trading on Tuesday October 2 or the release of the announcement. Animoca Brands finished the first half of FY 2018 with $2 million in cash and raised another $6 million just after the half ended.

Bionomics Ltd (ASX: BNO) shares have been placed into a trading halt pending an announcement regarding the results of its highly anticipated BNC210 Phase 2 clinical trial in patients with Post Traumatic Stress Disorder. Bionomics' shares are expected to remain halted until the commencement of trading on Tuesday. I'm very excited about the potential of the BNC210 product. According to CEO Dr Deborah Rathjen, "BNC210 has the potential to be an innovative treatment for patients with PTSD with a solid foundation of clinical data supportive of development not only in PTSD but also in anxiety disorders and conditions where there is co-morbid anxiety and depression."

Blue Sky Alternative Investments Ltd (ASX: BLA) shares have found themselves in a trading halt for the umpteenth time this year. However, on this occasion it could be a positive for the asset manager's long-suffering shareholders. According to the request, the trading halt has been called for pending an announcement by the company in relation to details of a material transaction with Oaktree Capital Management. Earlier this week the AFR suggested that Oaktree was preparing to sign on the dotted line for a five-year convertible note which could leave the private equity group with as much as a 30% in the listed company. The report suggests the notes would be in the range of $50 million to $60 million. Blue Sky's shares are expected to return to trade on Monday.

Motley Fool contributor James Mickleboro has no position in any of the stocks mentioned. The Motley Fool Australia has no position in any of the stocks mentioned. We Fools may not all hold the same opinions, but we all believe that considering a diverse range of insights makes us better investors. The Motley Fool has a disclosure policy. This article contains general investment advice only (under AFSL 400691). Authorised by Scott Phillips.

More on Share Market News

A man looks down with fright as he falls towards the ground.
Share Fallers

Why 29Metals, Guzman Y Gomez, Mesoblast, and Pilbara Minerals shares are falling today

These shares are having a tough time on Thursday. What's going on?

Read more »

Two happy excited friends in euphoria mood after winning in a bet with a smartphone in hand.
Share Gainers

Why Bravura, HMC, Magellan, and Perseus shares are pushing higher today

These shares are having a good session on Thursday. But why?

Read more »

Three young people lie in the surf on a beach wearing santa hats.
Share Market News

Will ASX 200 investors be gifted with a 'Santa rally'?

After a strong run in 2024, can the Santa rally send the ASX 200 to new records?

Read more »

A businessman stacks building blocks.
Technology Shares

Why has this ASX 200 tech stock rocketed 38% in a month?

The stars aligned for this stock over the past month.

Read more »

Three rockets heading to space
Share Gainers

3 ASX biotech shares rocketing 10% to 26% on BIG news!

Investors are sending these three ASX biotech stocks flying higher on Thursday.

Read more »

Broker looking at the share price.
Broker Notes

Here's the latest broker upgrades on ASX All Ords shares

Let's dive in.

Read more »

Woman shaking the hand of a man on a deal.
Mergers & Acquisitions

Up 146% in a year, ASX 200 stock marches higher on $950 million acquisition news

The ASX 200 company is expanding its renewable energy footprint.

Read more »

A man holds his head in his hands, despairing at the bad result he's reading on his computer.
Capital Raising

Guess which ASX All Ords stock just crashed 28%!

What's causing this share to crash deep into the red on Thursday? Let's find out.

Read more »